Kexing Biopharm Co., Ltd. (SHA:688136)

Kexing Biopharm Revenue

Kexing Biopharm had revenue of 306.62M CNY in the quarter ending September 30, 2026, a decrease of -31.43%. This brings the company's total for the last twelve months to 1.30B, down -14.26% year-over-year. In the year 2025, Kexing Biopharm had annual revenue of 1.53B with 9.03% growth. That makes Kexing Biopharm the 17,666th largest company in the world by revenue and 3,220th in China.

• Revenue (ttm): 1.30B
• Revenue Growth: -14.26%
• P/S Ratio: 2.44
• Revenue / Employee: 1.17M
• Employees: 1,109
• Market Cap: 3.18B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.17B 76.1%
• Export 366.29M 23.9%

Fiscal year ended Dec 31, 2025 See the full Kexing Biopharm breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.53B	127.10M	9.03%
Dec 31, 2024	1.41B	147.89M	11.75%
Dec 31, 2023	1.26B	-56.84M	-4.32%
Dec 31, 2022	1.32B	30.70M	2.39%
Dec 31, 2021	1.29B	64.88M	5.32%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error